Tandem Diabetes Care, Inc. (TNDM)
19.90
-0.53
(-2.59%)
USD |
NASDAQ |
Sep 04, 16:00
19.95
+0.05
(+0.25%)
After-Hours: 20:00
Tandem Diabetes Care Research and Development Expense (Quarterly) : 46.93M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 46.93M |
| March 31, 2026 | 46.04M |
| December 31, 2025 | 46.07M |
| September 30, 2025 | 47.88M |
| June 30, 2025 | 48.12M |
| March 31, 2025 | 50.22M |
| December 31, 2024 | 52.20M |
| September 30, 2024 | 51.11M |
| June 30, 2024 | 49.33M |
| March 31, 2024 | 46.24M |
| December 31, 2023 | 42.60M |
| September 30, 2023 | 41.97M |
| June 30, 2023 | 42.93M |
| March 31, 2023 | 42.16M |
| December 31, 2022 | 35.58M |
| September 30, 2022 | 67.81M |
| June 30, 2022 | 33.57M |
| March 31, 2022 | 33.16M |
| December 31, 2021 | 29.49M |
| September 30, 2021 | 24.10M |
| June 30, 2021 | 20.50M |
| March 31, 2021 | 17.96M |
| December 31, 2020 | 17.38M |
| September 30, 2020 | 16.09M |
| June 30, 2020 | 15.99M |
| Date | Value |
|---|---|
| March 31, 2020 | 14.12M |
| December 31, 2019 | 12.57M |
| September 30, 2019 | 12.04M |
| June 30, 2019 | 11.20M |
| March 31, 2019 | 9.389M |
| December 31, 2018 | 8.797M |
| September 30, 2018 | 7.999M |
| June 30, 2018 | 6.456M |
| March 31, 2018 | 5.975M |
| December 31, 2017 | 5.751M |
| September 30, 2017 | 4.914M |
| June 30, 2017 | 4.866M |
| March 31, 2017 | 5.13M |
| December 31, 2016 | 4.344M |
| September 30, 2016 | 6.154M |
| June 30, 2016 | 4.142M |
| March 31, 2016 | 4.169M |
| December 31, 2015 | 4.135M |
| September 30, 2015 | 5.093M |
| June 30, 2015 | 3.873M |
| March 31, 2015 | 3.863M |
| December 31, 2014 | 3.921M |
| September 30, 2014 | 4.508M |
| June 30, 2014 | 3.698M |
| March 31, 2014 | 3.663M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Modular Medical, Inc. | 3.87M |
| Senseonics Holdings, Inc. | 11.64M |
| NeuroPace, Inc. | 6.898M |
| Abbott Laboratories | 892.00M |
| Accuray, Inc. | 7.707M |